|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2004-8-20
|
|
pubmed:abstractText |
We investigated the possible use of clinical signs of chemotherapy-induced peripheral neurotoxicity (CIPN) or of nerve growth factor (NGF) circulating levels to predict the final outcome of CIPN.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:BogliunGG,
pubmed-author:BudaAA,
pubmed-author:CavalettiGG,
pubmed-author:ColomboNN,
pubmed-author:CundariSS,
pubmed-author:FranchiDD,
pubmed-author:La PresaM TMT,
pubmed-author:LissoniAA,
pubmed-author:MarzoratiLL,
pubmed-author:PiattiMM,
pubmed-author:WUJ HJH,
pubmed-author:ZannaCC,
pubmed-author:ZinconeAA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1439-42
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:15319252-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15319252-Carcinoma, Squamous Cell,
pubmed-meshheading:15319252-Cisplatin,
pubmed-meshheading:15319252-Female,
pubmed-meshheading:15319252-Humans,
pubmed-meshheading:15319252-Nerve Growth Factor,
pubmed-meshheading:15319252-Neurotoxicity Syndromes,
pubmed-meshheading:15319252-Paclitaxel,
pubmed-meshheading:15319252-Predictive Value of Tests,
pubmed-meshheading:15319252-Prognosis,
pubmed-meshheading:15319252-Sensation Disorders,
pubmed-meshheading:15319252-Treatment Outcome,
pubmed-meshheading:15319252-Uterine Cervical Neoplasms
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy.
|
|
pubmed:affiliation |
Dipartimento di Neuroscienze e Tecnologie Biomediche, Università di Milano Bicocca, Monza, Italy. guido.cavaletti@unimib.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
